LncRNA AWPPH and miRNA‐21 regulates cancer cell proliferation and chemosensitivity in triple‐negative breast cancer by interacting with each other

Autor: Jin-Yu Xiang, Huajun Qu, Wen-Jing Gong, Wei Zhang, Miao-Miao Yang, Ai-Na Liu

Publikováno v: Journal of Cellular Biochemistry. 120:14860-14866

Long-non-coding RNAs (lncRNA) AWPPH promotes the progression of liver and bladder cancer, indicating its oncogenic role. The current study aimed to explore the involvement of AWPPH in triple-negative breast cancer (TNBC). In the current study, we fou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31185c9f39951c30ab9f6a6ecf041db6
https://doi.org/10.1002/jcb.28747

Efficacy and safety of regorafenib or fruquintinib plus camrelizumab in patients with microsatellite stable and/or proficient mismatch repair metastatic colorectal cancer: an observational pilot study.

Autor: Feng-E JIANG, Hui-Juan ZHANG, Cai-Yan YU, Ai-Na LIU

Publikováno v: Neoplasma; 2021, Vol. 68 Issue 4, p861-866, 6p

Efficacy and safety of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy in HER2-negative breast cancer

Autor: Miao-Miao Yang, Hua Li, Ping Sun, Jiannan Liu, Huajun Qu, Ai-Na Liu

Publikováno v: Journal of Cancer Research and Therapeutics, Vol 15, Iss 7, Pp 1561-1566 (2019)

Context: Nanoparticle albumin-bound paclitaxel (Nab-PTX) is a form of paclitaxel bound to albumin nanoparticles and is used widely in a neoadjuvant setting for patients with breast cancer. Aims: We conducted a retrospective study to compare the effic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42683cdea8ff116c0b370ec5ef0ef7be
https://doi.org/10.4103/jcrt.jcrt_241_19

Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial

Autor: Jing, Huang, Qing-Xia, Fan, Li, Chen, Ai-Na, Liu, Rui-Gang, Cai, Xue-Zhi, Hao, Jin-Wan, Wang, Yan, Sun

Publikováno v: Chinese medical journal. 124(23)

Esophageal cancer is the sixth most common cause of cancer-related death worldwide. Prior studies had demonstrated potential synergistic antitumor activity of gemcitabine in combination with cisplatin. Therefore, we studied the efficacy and tolerabil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::45f3e3d4561c4c7a2db7043cf8808ed8
https://pubmed.ncbi.nlm.nih.gov/22340334

Treatment of Cushing Disease With Pituitary-Targeting Seliciclib.

Autor: Liu NA; Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Ben-Shlomo A; Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Carmichael JD; Pituitary Center, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA., Wang C; Department of Medicine, The Lundquist Institute and Harbor-UCLA Medical Center, Torrance, CA 90509, USA., Swerdloff RS; Department of Medicine, The Lundquist Institute and Harbor-UCLA Medical Center, Torrance, CA 90509, USA., Heaney AP; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90024, USA., Barkhoudarian G; Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Kelly D; Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Noureddin M; Karsh Division of Gastroenterology and Hepatology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Lu L; Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China., Desai M; Southern California Permanente Group-Antelope Valley, Lancaster, CA 93534, USA., Stolyarov Y; Optum, Santa Ana, CA 92704, USA., Yuen K; Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ 85013, USA., Mamelak AN; Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Mirocha J; Biostatistics Core, Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Tighiouart M; Biostatistics Core, Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Melmed S; Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Feb 15; Vol. 108 (3), pp. 726-735.